Immunitas Therapeutics
Dr. Iannone is Director of Venture Investments of Leaps by Bayer, where he is responsible for developing investment cases and deal execution. As an investor, Lucio also serves as board member for Pyxis Oncology, Khloris Biosciences, Casebia Therapeutics and Axxam. Before joining Bayer, Lucio had several senior roles in biotechnology companies and venture capital firms. He began his career at Imperial College London in the Department of Experimental Medicine where he received his Ph.D.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Immunitas Therapeutics
Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single-cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering.